Jacob Waugh serves as Executive at Revance Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jacob Waugh has executed 16 insider transactions totaling $2.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 19, 2015 involved selling 3,131 shares valued at $81.2K.
Jacob Waugh currently holds 28,413 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jacob Waugh has been a net seller of RVNC stock. They have purchased $0 and sold $2.6M worth of shares.
Jacob Waugh's most recent insider trade was on May 19, 2015, when they sold 3,131 shares at $25.94 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 17, 2014 | RVNC | $239.9K | Sale | 11,632 | $20.62 | Discretionary |
| Sep 17, 2014 | RVNC | $14.9K | Sale | 700 | $21.26 | Discretionary |
| Sep 17, 2014 | RVNC | $531.6K | Sale | 25,833 | $20.58 | Discretionary |
| Sep 17, 2014 | RVNC | $53.2K | Sale | 2,500 | $21.27 | Discretionary |
| Sep 17, 2014 | RVNC | $12.8K | Option Exercise | 5,000 | $2.55 | Discretionary |
| Sep 17, 2014 | RVNC | $14.4K | Option Exercise | 5,666 | $2.55 | Discretionary |
| Sep 17, 2014 | RVNC | $421.4K | Option Exercise | 48,437 | $8.70 | Discretionary |
| Sep 17, 2014 | RVNC | $78.8K | Option Exercise | 8,611 | $9.15 | Discretionary |
| Sep 17, 2014 | RVNC | $185.1K | Sale | 8,611 | $21.50 | Discretionary |
| Sep 17, 2014 | RVNC | $909.2K | Sale | 44,137 | $20.60 | Discretionary |
| Sep 17, 2014 | RVNC | $91.5K | Sale | 4,300 | $21.28 | Discretionary |
| Sep 17, 2014 | RVNC | $11.0K | Option Exercise | 1,666 | $6.60 | Discretionary |
| Aug 18, 2014 | RVNC | $611.8K | Sale | 25,000 | $24.47 | Discretionary |
| May 19, 2014 | RVNC | $805.5K | Award | 25,000 | $32.22 | Discretionary |